Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Important safety information: Semaglutide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
It also includes dosing considerations, site-rotation tips, and helpful ways to minimize discomfort
Use phone alarms, medication apps, or tie your injections to a weekly routine, like a specific day or activity
CMS contracts Humana as a central processor, and the prior authorization and claims go directly to that processor
